InsiderTrades

Form 4 for NVCR NovoCure Ltd

Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001645113-22-000016 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-07 2022-03-03+ NVCR Burke William Patrick CHRO S - Sale $71.43 -1,367 58.1K -2% -$97.6K
D 2022-03-07 2022-03-03 NVCR Burke William Patrick CHRO A - Grant $0.00 +7,445 58.4K +15% $0
DM 2022-03-07 2022-03-03 NVCR Burke William Patrick CHRO A - Grant $80.59 +17.4K 4,361 New +$1.40M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2022-03-04 S D 1,026 $70.41 57,028 D — —
2 Common Ordinary Shares 2022-03-03 A A 7,445 $0.00 58,395 D — —
3 Common Ordinary Shares 2022-03-03 S D 341 $74.50 58,054 D — —
4 Derivative Options to Buy Ordinary Shares 2022-03-03 A A 13,038 $80.59 13,038 D $80.59 · 2023-03-01 to 2032-02-29 13,038 Ordinary Shares (F3) Options to buy 13,038 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
5 Derivative Options to Buy Ordinary Shares 2022-03-03 A A 4,361 $80.59 4,361 D $80.59 · 2023-03-01 to 2032-02-29 4,361 Ordinary Shares (F4) Options to buy 4,361 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.